CA Stock MarketDetailed Quotes

MSCL Satellos Bioscience Inc

Watchlist
  • 0.700
  • 0.0000.00%
15min DelayTrading Nov 28 11:39 ET
79.52MMarket Cap-2800P/E (TTM)

Satellos Bioscience Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-9.45%-4.38M
-46.00%-5.66M
-499.24%-7.13M
-156.97%-14.5M
-384.06%-5.44M
-153.25%-4M
-356.99%-3.88M
43.14%-1.19M
-12.10%-5.64M
10.86%-1.12M
Net income from continuing operations
-153.23%-9.05M
-46.68%-6.04M
-314.71%-6.91M
-40.34%-15.89M
-28.87%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
26.98%-11.32M
-100.64%-5.07M
Operating gains losses
107.83%120K
-115.57%-185K
-23,666.67%-707K
-4,728.00%-1.16M
---816K
---1.53M
--1.19M
--3K
226.43%25K
----
Depreciation and amortization
0.00%3K
200.00%3K
100.00%2K
-97.92%7K
-84.62%2K
-97.26%3K
-99.07%1K
-99.06%1K
103.40%337K
-88.06%13K
Asset impairment expenditure
----
----
----
--0
--0
----
----
----
--2.89M
----
Remuneration paid in stock
-68.15%237K
87.30%693K
266.17%736K
50.63%2.17M
242.97%854K
140.15%744K
-11.71%370K
-56.47%201K
48.22%1.44M
-73.07%249K
Other non cashItems
----
----
----
----
----
----
----
----
-101.42%-140K
----
Change In working capital
-15.87%350K
90.27%-134K
-193.36%-253K
-62.76%369K
36.65%1.06M
517.04%416K
-259.93%-1.38M
149.67%271K
304.06%991K
356.62%775K
-Change in receivables
27,000.00%813K
62.93%-109K
-259.18%-312K
-220.97%-323K
-356.00%-228K
575.68%3K
-184.94%-294K
761.67%196K
496.15%267K
-118.75%-50K
-Change in prepaid assets
-15.00%-69K
-1,684.21%-301K
-569.23%-61K
-5,000.00%-102K
-669.23%-74K
-68.80%-60K
2,370.74%19K
-33.04%13K
92.80%-2K
195.68%13K
-Change in payables and accrued expense
-183.30%-394K
125.05%276K
93.55%120K
9.37%794K
67.61%1.36M
831.64%473K
-314.34%-1.1M
111.58%62K
285.93%726K
1,073.73%812K
Cash from discontinued investing activities
Operating cash flow
-9.45%-4.38M
-46.00%-5.66M
-499.24%-7.13M
-150.75%-14.5M
-330.40%-5.44M
-153.25%-4M
-356.99%-3.88M
43.14%-1.19M
-14.89%-5.78M
-0.26%-1.26M
Investing cash flow
Cash flow from continuing investing activities
177,150.00%17.71M
33,714.29%2.35M
-2.1M
-584,500.00%-17.54M
-17.52M
-350.86%-10K
-7K
0
-100.17%-3K
0
Net PPE purchase and sale
--0
42.86%-4K
---2K
-500.00%-18K
---1K
-350.86%-10K
---7K
--0
58.60%-3K
--0
Net investment purchase and sale
--17.71M
--2.36M
---2.1M
---17.52M
---17.52M
--0
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
177,150.00%17.71M
33,714.29%2.35M
---2.1M
-584,500.00%-17.54M
---17.52M
-350.86%-10K
---7K
--0
-100.17%-3K
--0
Financing cash flow
Cash flow from continuing financing activities
110.95%221K
-99.97%16K
0
1,739.03%51.03M
0
-172.57%-2.02M
50.8M
2.25M
-62.76%2.78M
94.69%-7K
Net issuance payments of debt
--0
--0
--0
---284K
--0
---2.53M
--1K
--2.24M
--0
--0
Net common stock issuance
--0
----
----
1,069.84%32.46M
--0
--0
----
----
-60.80%2.78M
97.79%-7K
Cash dividends paid
----
----
----
--0
--0
----
----
----
--0
--0
Proceeds from stock option exercised by employees
--221K
----
----
--18.34M
--0
--0
----
----
--0
--0
Interest paid (cash flow from financing activities)
----
----
----
---93K
--0
----
----
----
--0
--0
Net other financing activities
----
----
----
--603K
--0
----
----
--8K
----
----
Cash from discontinued financing activities
Financing cash flow
110.95%221K
-99.97%16K
--0
1,739.03%51.03M
--0
-172.57%-2.02M
--50.8M
--2.25M
-62.76%2.78M
94.69%-7K
Net cash flow
Beginning cash position
-79.83%9.83M
339.48%13.11M
1,046.93%22.07M
-60.50%1.92M
1,313.70%44.26M
2,424.03%48.73M
7.51%2.98M
-60.50%1.92M
578.86%4.87M
-50.09%3.13M
Current changes in cash
324.77%13.55M
-107.01%-3.29M
-969.21%-9.23M
761.58%18.99M
-1,931.59%-22.96M
-601.98%-6.03M
5,631.59%46.92M
150.71%1.06M
-169.09%-2.87M
19.29%-1.13M
Effect of exchange rate changes
-97.25%43K
100.51%6K
14,000.00%278K
1,611.84%1.15M
1,088.31%761K
215,824.14%1.56M
-36,890.97%-1.17M
-18.62%-2K
-5,163.16%-76K
-5,232.41%-77K
End cash Position
-47.08%23.42M
-79.83%9.83M
339.48%13.11M
1,046.93%22.07M
1,046.93%22.07M
1,313.86%44.26M
2,424.03%48.73M
7.51%2.98M
-60.50%1.92M
-60.50%1.92M
Free cash from
-9.18%-4.38M
-45.84%-5.66M
-499.41%-7.13M
-150.93%-14.52M
-330.48%-5.44M
-153.53%-4.01M
-357.81%-3.88M
43.17%-1.19M
-14.78%-5.79M
0.32%-1.26M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -9.45%-4.38M-46.00%-5.66M-499.24%-7.13M-156.97%-14.5M-384.06%-5.44M-153.25%-4M-356.99%-3.88M43.14%-1.19M-12.10%-5.64M10.86%-1.12M
Net income from continuing operations -153.23%-9.05M-46.68%-6.04M-314.71%-6.91M-40.34%-15.89M-28.87%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M26.98%-11.32M-100.64%-5.07M
Operating gains losses 107.83%120K-115.57%-185K-23,666.67%-707K-4,728.00%-1.16M---816K---1.53M--1.19M--3K226.43%25K----
Depreciation and amortization 0.00%3K200.00%3K100.00%2K-97.92%7K-84.62%2K-97.26%3K-99.07%1K-99.06%1K103.40%337K-88.06%13K
Asset impairment expenditure --------------0--0--------------2.89M----
Remuneration paid in stock -68.15%237K87.30%693K266.17%736K50.63%2.17M242.97%854K140.15%744K-11.71%370K-56.47%201K48.22%1.44M-73.07%249K
Other non cashItems ---------------------------------101.42%-140K----
Change In working capital -15.87%350K90.27%-134K-193.36%-253K-62.76%369K36.65%1.06M517.04%416K-259.93%-1.38M149.67%271K304.06%991K356.62%775K
-Change in receivables 27,000.00%813K62.93%-109K-259.18%-312K-220.97%-323K-356.00%-228K575.68%3K-184.94%-294K761.67%196K496.15%267K-118.75%-50K
-Change in prepaid assets -15.00%-69K-1,684.21%-301K-569.23%-61K-5,000.00%-102K-669.23%-74K-68.80%-60K2,370.74%19K-33.04%13K92.80%-2K195.68%13K
-Change in payables and accrued expense -183.30%-394K125.05%276K93.55%120K9.37%794K67.61%1.36M831.64%473K-314.34%-1.1M111.58%62K285.93%726K1,073.73%812K
Cash from discontinued investing activities
Operating cash flow -9.45%-4.38M-46.00%-5.66M-499.24%-7.13M-150.75%-14.5M-330.40%-5.44M-153.25%-4M-356.99%-3.88M43.14%-1.19M-14.89%-5.78M-0.26%-1.26M
Investing cash flow
Cash flow from continuing investing activities 177,150.00%17.71M33,714.29%2.35M-2.1M-584,500.00%-17.54M-17.52M-350.86%-10K-7K0-100.17%-3K0
Net PPE purchase and sale --042.86%-4K---2K-500.00%-18K---1K-350.86%-10K---7K--058.60%-3K--0
Net investment purchase and sale --17.71M--2.36M---2.1M---17.52M---17.52M--0--0--0--0----
Cash from discontinued investing activities
Investing cash flow 177,150.00%17.71M33,714.29%2.35M---2.1M-584,500.00%-17.54M---17.52M-350.86%-10K---7K--0-100.17%-3K--0
Financing cash flow
Cash flow from continuing financing activities 110.95%221K-99.97%16K01,739.03%51.03M0-172.57%-2.02M50.8M2.25M-62.76%2.78M94.69%-7K
Net issuance payments of debt --0--0--0---284K--0---2.53M--1K--2.24M--0--0
Net common stock issuance --0--------1,069.84%32.46M--0--0---------60.80%2.78M97.79%-7K
Cash dividends paid --------------0--0--------------0--0
Proceeds from stock option exercised by employees --221K----------18.34M--0--0----------0--0
Interest paid (cash flow from financing activities) ---------------93K--0--------------0--0
Net other financing activities --------------603K--0----------8K--------
Cash from discontinued financing activities
Financing cash flow 110.95%221K-99.97%16K--01,739.03%51.03M--0-172.57%-2.02M--50.8M--2.25M-62.76%2.78M94.69%-7K
Net cash flow
Beginning cash position -79.83%9.83M339.48%13.11M1,046.93%22.07M-60.50%1.92M1,313.70%44.26M2,424.03%48.73M7.51%2.98M-60.50%1.92M578.86%4.87M-50.09%3.13M
Current changes in cash 324.77%13.55M-107.01%-3.29M-969.21%-9.23M761.58%18.99M-1,931.59%-22.96M-601.98%-6.03M5,631.59%46.92M150.71%1.06M-169.09%-2.87M19.29%-1.13M
Effect of exchange rate changes -97.25%43K100.51%6K14,000.00%278K1,611.84%1.15M1,088.31%761K215,824.14%1.56M-36,890.97%-1.17M-18.62%-2K-5,163.16%-76K-5,232.41%-77K
End cash Position -47.08%23.42M-79.83%9.83M339.48%13.11M1,046.93%22.07M1,046.93%22.07M1,313.86%44.26M2,424.03%48.73M7.51%2.98M-60.50%1.92M-60.50%1.92M
Free cash from -9.18%-4.38M-45.84%-5.66M-499.41%-7.13M-150.93%-14.52M-330.48%-5.44M-153.53%-4.01M-357.81%-3.88M43.17%-1.19M-14.78%-5.79M0.32%-1.26M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data